New drink flavors aim to help kidney patients stay nourished
NCT ID NCT06892249
First seen Jun 27, 2026 · Last updated Jul 29, 2026 · Updated 2 times
Summary
This study tested two flavors of a high-energy, low-protein drink called Renalive® LP in 74 adults with chronic kidney disease stages 3b-5. Participants drank the formula as a meal replacement or supplement for 4 weeks. The goal was to see if the drink was suitable and helped maintain body weight and nutrition without harming kidney function.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CKD are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Kaosiung Chang Gung Memorial Hospital
Kaohsiung City, Taiwan
-
Taipei TzuChi Hospital
New Taipei City, Taiwan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a phone app be the key to managing kidney disease?
- Can a pill tailored to inflammation boost red blood cells in kidney disease?
- 3D infrared scans may reveal hidden malnutrition in anorexia — a study puts the idea to the test
- Dialysis duel: does higher fluid volume or lower sodium improve patient outcomes?
- 30 patients to test if nutrition tracking boosts wound healing
- Study links gum health to rare kidney diseases